Related Experiment Video
Updated: Mar 31, 2026

10:54
Detection of Retrotransposition Activity of Hot LINE-1s by Long-Distance Inverse PCR
Published on: July 27, 2019
9.2K
L1 retrotransposition in human neural progenitor cells.
Nicole G Coufal1, José L Garcia-Perez, Grace E Peng
1Laboratory of Genetics, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA.
Nature
|August 7, 2009
Summary
New research shows that Long Interspersed Element 1 (LINE-1 or L1) retrotransposons can become active in adult human brain cells. This suggests that L1 retrotransposition may contribute to somatic mosaicism in the human brain.
Area of Science:
- Genomics
- Neuroscience
- Molecular Biology
Background:
- Long Interspersed Element 1 (LINE-1 or L1) retrotransposons significantly influence the human genome.
- Retrotransposition in germline or early development is crucial for L1 evolutionary success.
- The impact of L1 retrotransposition on somatic cells, particularly in the brain, remains largely unknown.
Purpose of the Study:
- To investigate the potential for engineered human L1 retrotransposition in human neural progenitor cells.
- To determine if endogenous L1s exhibit increased copy numbers in specific regions of the adult human brain compared to other tissues.
Main Methods:
- Utilized human fetal brain-derived neural progenitor cells and human embryonic stem cell-derived neural progenitor cells.
- Employed engineered human L1s to assess retrotransposition activity in vitro.
- Developed a quantitative multiplex polymerase chain reaction (PCR) assay.
- Compared endogenous L1 copy numbers in various adult human brain regions (hippocampus) with those in heart and liver genomic DNA.
Main Results:
- Human neural progenitor cells, both fetal and embryonic stem cell-derived, support the retrotransposition of engineered human L1s in vitro.
- A quantitative multiplex PCR assay revealed an increased copy number of endogenous L1s in the human hippocampus and other brain regions.
- Endogenous L1 copy numbers were higher in brain tissues than in genomic DNA from the same donor's heart or liver.
Conclusions:
- De novo L1 retrotransposition events are suggested to occur in the human brain.
- These events have the potential to contribute to somatic mosaicism within the human brain.
- The findings highlight a novel aspect of L1 activity in the central nervous system.
Related Concept Videos
Non-LTR Retrotransposons
14.0K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K
LTR Retrotransposons
20.5K
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
20.5K
Methods of Nuclear Reprogramming
2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K

